NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
Show detailsBibliographic details: Goralczyk AD, Bari N, Abu-Ajaj W, Lorf T, Ramadori G, Friede T, Obed A. Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials. American Journal of Transplantation 2012; 12(10): 2601-2607. [PubMed: 22813081]
Abstract
Liver transplant recipients are at high risk of developing acute and chronic renal failure. Moreover, introduction of the model for end-stage liver disease (MELD) score for primary allocation of liver grafts favors patients with pretransplant kidney dysfunction, which in turn have a higher risk of posttransplant renal failure. Calcineurin inhibitors (CNI) further increase the risk of renal failure and therefore sparing CNI with the use of mycophenolate mofetil (MMF) may improve renal function. MMF may either be used de novo in the immediate posttransplant period in combination with low-dose CNI (scenario 1) or patients that receive immunosuppression based on CNI may be converted to MMF in combination with minimization or elimination of CNI (scenario 2). Although many retrospective cohort studies and nonrandomized trials have implicated efficacy of this approach the evidence from randomized controlled studies has not been summarized. In the current review we report the results of a systematic review and meta-analysis of randomized controlled trials.
© Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.
- A comparison of mycophenolate mofetil and calcineurin inhibitor as maintenance immunosuppression for kidney transplant recipients: A meta-analysis of randomized controlled trials.[Turk J Med Sci. 2021]A comparison of mycophenolate mofetil and calcineurin inhibitor as maintenance immunosuppression for kidney transplant recipients: A meta-analysis of randomized controlled trials.Deng J, Lu Y, He L, Ou J, Xie H. Turk J Med Sci. 2021 Jun 28; 51(3):1080-1091. Epub 2021 Jun 28.
- Review Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis.[Transplantation. 2009]Review Calcineurin inhibitor sparing with mycophenolate in kidney transplantation: a systematic review and meta-analysis.Moore J, Middleton L, Cockwell P, Adu D, Ball S, Little MA, Ready A, Wheatley K, Borrows R. Transplantation. 2009 Feb 27; 87(4):591-605.
- Review Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress.[Am J Transplant. 2009]Review Mycophenolate mofetil and calcineurin-inhibitor reduction: recent progress.Grinyó JM, Cruzado JM. Am J Transplant. 2009 Nov; 9(11):2447-52. Epub 2009 Sep 22.
- Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial.[Transplant Proc. 2010]Conversion from calcineurin inhibitor to either mycophenolate mofetil or sirolimus improves renal function in liver transplant recipients with chronic kidney disease: results of a prospective randomized trial.Herlenius G, Felldin M, Nordén G, Olausson M, Bäckman L, Gustafsson B, Friman S. Transplant Proc. 2010 Dec; 42(10):4441-8.
- Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure.[Transplantation. 2009]Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure.Groetzner J, Kaczmarek I, Schulz U, Stegemann E, Kaiser K, Wittwer T, Schirmer J, Voss M, Strauch J, Wahlers T, et al. Transplantation. 2009 Mar 15; 87(5):726-33.
- Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion:...Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials - Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews
Your browsing activity is empty.
Activity recording is turned off.
See more...